In the meantime, TD Cowen initiated its Aurora Cannabis Inc [ACB] rating to a Buy in a research note published recently. A number of analysts have revised their coverage, including Canaccord Genuity’s analysts, who increased its forecast for the stock in early February from “a Hold” to “a Buy”. Canaccord Genuity also remained covering ACB and has increased its forecast on September 21, 2022 with a “Hold” recommendation from previously “Sell” rating. Cantor Fitzgerald revised its rating on June 24, 2022. It rated ACB as “an Overweight” which previously was an “a Neutral”.
Price Performance Review of ACB
On Tuesday, Aurora Cannabis Inc [NASDAQ:ACB] saw its stock jump 1.98% to $5.16. Over the last five days, the stock has gained 11.93%. Aurora Cannabis Inc shares have risen nearly 21.41% since the year began. Nevertheless, the stocks have fallen -24.23% over the past one year. While a 52-week high of $8.14 was reached on 02/10/25, a 52-week low of $3.42 was recorded on 02/03/25. SMA at 50 days reached $4.50, while 200 days put it at $5.05.
Levels Of Support And Resistance For ACB Stock
The 24-hour chart illustrates a support level at 5.06, which if violated will result in even more drops to 4.95. On the upside, there is a resistance level at 5.26. A further resistance level may holdings at 5.35. The Relative Strength Index (RSI) on the 14-day chart is 66.04, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.25, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 10.59%. Stochastics %K at 86.85% indicates the stock is a selling.
